SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-22-000033
Filing Date
2022-10-28
Accepted
2022-10-28 13:44:57
Documents
73
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20220930.htm   iXBRL 10-Q 2112171
2 EX-10.1 exhibit-101.htm EX-10.1 3569
3 EX-10.2 exhibit_102.htm EX-10.2 18490
4 EX-31.1 exhibit311-30sep22x10q.htm EX-31.1 8896
5 EX-31.2 exhibit312-30sep22x10q.htm EX-31.2 9139
6 EX-32.1 exhibit321-30sep22x10q.htm EX-32.1 5249
  Complete submission text file 0001048477-22-000033.txt   8446934

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20220930.xsd EX-101.SCH 46030
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20220930_cal.xml EX-101.CAL 72643
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20220930_def.xml EX-101.DEF 238265
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20220930_lab.xml EX-101.LAB 544781
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20220930_pre.xml EX-101.PRE 368000
67 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20220930_htm.xml XML 1759365
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 221340617
SIC: 2834 Pharmaceutical Preparations